Form 4: GeneDx Holdings Corp. Director Leproust Reports Stock Transactions

Emily M. Leproust, a director at GeneDx Holdings Corp., reported the acquisition and disposal of Class A Common Stock and Restricted Stock Units on June 20, 2024.

Summary

• On June 20, 2024, Emily M. Leproust, a director of GeneDx Holdings Corp., reported transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
• Leproust acquired 5,828 shares of Class A Common Stock at a price of $0 related to the vesting of Restricted Stock Units.
• Leproust also disposed of 5,828 shares of Class A Common Stock.
• Following these transactions, Leproust beneficially owns 8,352 shares of Class A Common Stock.
• The RSUs vest the earlier of the next annual meeting or the first anniversary of the grant date, contingent upon continued service to the Issuer.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly altering the ownership structure.
• The vesting of RSUs impacts the director's compensation and alignment with shareholder interests.

Key Dates